About INSIGHT MOLECULAR DIAGNOSTICS INC
iMDx is a company focused on precision diagnostics in oncology and transplantation, offering molecular diagnostic solutions for clinical and research use. The company aims to deliver actionable insights that support decision-making across healthcare settings.
Development of blood-based transplant monitoring tests using donor-derived cell-free DNA (dd-cfDNA)Creation of clinical assays for quantifying dd-cfDNA levels in plasma following kidney transplantationResearch use only dd-cfDNA test kits for transplant monitoringIn-development tests for measuring genomic copy number instability in circulating tumor DNA for cancer monitoring27-gene expression laboratory-developed tests for assessing tumor microenvironment and predicting immunotherapy response
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INSIGHT MOLECULAR DIAGNOSTICS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.